Clinical Trial Update: Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating autologous MitoCell transplantation for idiopathic Parkinson's disease, focusing on safety, tolerability, and efficacy; recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• MitoCell

Snippet

Sponsor: Taiwan Mitochondrion Applied Technology Co., Ltd. | Conditions: Idiopathic Parkinson's Disease | Phase 1 | Status: NOT_YET_RECRUITING